ALISSA HEALTHCARE RESEARCH LIMITED — Folic Importer Profile
Pharmaceutical Importer · #15 buyer for Folic · $449.1K import value · 20 shipments · UNITED KINGDOM · DGFT Verified
ALISSA HEALTHCARE RESEARCH LIMITED is the #15 importer of Folic from India with $449.1K in import value and 20 verified shipments. ALISSA HEALTHCARE RESEARCH LIMITED holds a 0.8% market share in Folic imports based in UNITED KINGDOM. The company sources from 3 verified suppliers across 10 formulations shipped to 1 country.
ALISSA HEALTHCARE RESEARCH LIMITED — Folic Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Folic to ALISSA HEALTHCARE RESEARCH LIMITED?
Verified from 20 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MARS THERAPEUTICS PRIVATE LIMITED | $384.7K | 18 | 85.7% |
| MARS THERAPEUTICS AND CHEMICALS LIMITED | $32.6K | 1 | 7.2% |
| MARS THERAPEUTICS CHEMICALS LIMITED | $31.8K | 1 | 7.1% |
ALISSA HEALTHCARE RESEARCH LIMITED sources Folic from 3 verified Indian suppliers based on 20 customs records. The primary supplier is MARS THERAPEUTICS PRIVATE LIMITED accounting for 85.7% of imports.
How Does ALISSA HEALTHCARE RESEARCH LIMITED Compare to Nearest Folic Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | EURIMEX PHARMA. | FRANCE | $465.3K | 20 | $23.3K |
| 3 | ETHIOPIAN PHARMACEUTICALS SUPPLY AG | ETHIOPIA | $450.0K | 9 | $50.0K |
| 15 | ALISSA HEALTHCARE RESEARCH LIMITED ★ | UNITED KINGDOM | $449.1K | 20 | $22.5K |
| 11 | SHREE HARI INTERNATIONAL LLC | UNITED STATES | $400.0K | 8 | $50.0K |
| 16 | HIGEN COMPANY | IRAQ | $400.0K | 8 | $50.0K |
ALISSA HEALTHCARE RESEARCH LIMITED ranks #15 among 1,433 Folic importers from India. Average shipment value of $22.5K compared to the market average of $8.0K. The closest competitors by value are EURIMEX PHARMA. and ETHIOPIAN PHARMACEUTICALS SUPPLY AG.
Where Does ALISSA HEALTHCARE RESEARCH LIMITED Import Folic To?
Destination countries from 20 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $449.1K | 20 | 100.0% |
ALISSA HEALTHCARE RESEARCH LIMITED imports Folic to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $449.1K.
What Folic Formulations Does ALISSA HEALTHCARE RESEARCH LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| (MEDICINES FINISHED PRODUCTS) FOLIC ACID5MG TABLETS (AS PER INV ) | $97.5K | 5 |
| FOLIC ACID 5MG TABLETS (MEDICINES FINISHED PRODUCTS) | $65.2K | 4 |
| FOLIC ACID 5MG TABLETS (MEDICINES FINISH | $63.5K | 2 |
| MEDICINES FINISHED PRODUCTS FOLIC ACID5MG TABLETS AS PER INV | $33.6K | 1 |
| MEDICINES FINISHED PRODUCT -FOLIC ACID 5MG TABLETS | $32.6K | 1 |
| FOLIC ACID 5MG TABLETS (MEDICINES FINISHED PRODUCTS)NOS | $32.3K | 3 |
| (Medicines Finished Products)FOLIC ACID | $32.2K | 1 |
| MEDICINES FINISHED PRODUCTS FOLIC ACID5MG TABLETS | $31.8K | 1 |
| FOLIC ACID 5MG TABLETS(MEDICINES FINISHE | $30.9K | 1 |
| (MEDICINES FINISHED PRODUCTS) FOLIC ACID | $29.6K | 1 |
ALISSA HEALTHCARE RESEARCH LIMITED imports 10 distinct Folic formulations from India. The top formulation is (MEDICINES FINISHED PRODUCTS) FOLIC ACID5MG TABLETS (AS PER with 5 shipments worth $97.5K.
Regulatory Requirements: Importing Folic into United Kingdom
What ALISSA HEALTHCARE RESEARCH LIMITED and other importers must comply with to import Folic from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Folic
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Folic from India and How Much Does ALISSA HEALTHCARE RESEARCH LIMITED Import?
India exported $11.4M worth of Folic through 5,361 shipments from 693 suppliers to 148 countries, serving 1,433 buyers globally. ALISSA HEALTHCARE RESEARCH LIMITED imports $449.1K of this total, accounting for 0.8% of India's Folic exports with 20 shipments from UNITED KINGDOM. This is verified from 20 customs shipment records covering 10 distinct formulations.
What Is the Average Order Value for ALISSA HEALTHCARE RESEARCH LIMITED's Folic Imports?
ALISSA HEALTHCARE RESEARCH LIMITED's average Folic order value is $22.5K per consignment, based on 20 shipments totaling $449.1K. ALISSA HEALTHCARE RESEARCH LIMITED is based in UNITED KINGDOM and ranks #15 among all Folic importers from India by value. The company sources from 3 verified suppliers in India.
Who Supplies Folic to ALISSA HEALTHCARE RESEARCH LIMITED?
ALISSA HEALTHCARE RESEARCH LIMITED sources Folic from 3 verified Indian suppliers: MARS THERAPEUTICS PRIVATE LIMITED ($384.7K, 85.7%), MARS THERAPEUTICS AND CHEMICALS LIMITED ($32.6K, 7.2%), MARS THERAPEUTICS CHEMICALS LIMITED ($31.8K, 7.1%). This is based on 20 customs records.
How Does ALISSA HEALTHCARE RESEARCH LIMITED Compare to Other Folic Importers?
ALISSA HEALTHCARE RESEARCH LIMITED ranks #15 among 1,433 Folic importers from India with a 0.8% market share. The top 3 importers are PLANET PHARMA ($2.3M), DISTRIMEX, ($1.3M), DISTRIMEX ($1.1M). ALISSA HEALTHCARE RESEARCH LIMITED processed 20 shipments from UNITED KINGDOM.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Folic — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Folic shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ALISSA HEALTHCARE RESEARCH LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ALISSA HEALTHCARE RESEARCH LIMITED's capped import value divided by total capped export value for Folic across all Indian exporters.
- 5.Verified Records: This page is backed by 20 individual customs records matching ALISSA HEALTHCARE RESEARCH LIMITED importing Folic, covering 10 formulations from 3 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 148+ countries, 1,433+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Folic Import Data for ALISSA HEALTHCARE RESEARCH LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for ALISSA HEALTHCARE RESEARCH LIMITED's Folic imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ALISSA HEALTHCARE RESEARCH LIMITED
Company Profile
Multiple products · $0 total trade · Multiple categories
ALISSA HEALTHCARE RESEARCH LIMITED × Folic
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ALISSA HEALTHCARE RESEARCH LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Folic. For current order-level data, contact TransData Nexus.